The Deal Register
Database › Equity financing › Innocan Pharma Announces Public Filing of Amended Registration…

Equity financing

Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering

Lane
Equity financing
Announced
10 Dec 2025
Province
Alberta
Industry
Healthcare & life sciences
Status
Announced
What the filing says
Innocan Pharma Corporation (" Innocan " or the " Company ") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that, further to its press release of July 23, 2025, it has publicly filed an amendment to its registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the " SEC ") relating to a proposed public offering of units (each, a " Unit " and collectively, the " Units ") in the United States.
Source

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe